Monashee Investment Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$146.04 - $225.78 $2.19 Million - $3.39 Million	15,000 New	15,000 $2.19 Million
Q3 2018 Nov 13, 2018	SELL	$207.3 - $300.31 $1.04 Million - $1.5 Million	-5,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$101.55 - $313.9 $507,750 - $1.57 Million	5,000 New	5,000 $1.4 Million
Q1 2018 May 10, 2018	SELL	$93.35 - $149.04 $1.54 Million - $2.46 Million	-16,500 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$39.35 - $97.37 $649,275 - $1.61 Million	16,500	16,500 $1.52 Million

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.9B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.